Hydroxychloroquine use should be avoided outside of hospitals, FDA warns
April 25 2020, 08:00
The U.S. Food and Drug Administration (FDA) on Friday warned against the use of two antimalarial drugs that have been touted as possible treatment options for the novel coronavirus following reports of “serious heart rhythm problems” in COVID-19 patients treated with the medications.
The U.S. Food and Drug Administration (FDA) on Friday warned against the use of two antimalarial drugs that have been touted as possible treatment options for the novel coronavirus following reports of “serious heart rhythm problems” in COVID-19 patients treated with the medications.
Source:
FOX News